Role of glycosaminoglycans of biglycan in BMP-2 signaling

Biochemical and Biophysical Research Communications

Volumn 405, Issue 2, 2011, Pages 262-266

  Miguez, P A ^a   Terajima, M ^b   Nagaoka, H ^b   Mochida, Y ^c   Yamauchi, M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Hamner Institutes for Health Sciences   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Biglycan; BMP 2; C2C12 cells; Microcomputed tomography; Osteogenesis; Smad pathway

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; GLYCOSAMINOGLYCAN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MANDIBLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BIGLYCAN; BONE MORPHOGENETIC PROTEIN 2; GLYCOSAMINOGLYCANS; MALE; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

RATTUS;

EID: 79651474448     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.022     Document Type: Article

References (32)

1. Fisher L.W., Termine J.D., Young M.F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 1989, 264:4571-4576.
2. Stocker G., Meyer H.E., Wagener C., Greiling H. Purification and N-terminal amino acid sequence of a chondroitin sulphate/dermatan sulphate proteoglycan isolated from intima/media preparations of human aorta. Biochem. J. 1991, 274(Pt 2):415-420.
3. Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., Border W.A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 1994, 302(Pt 2):527-534.
4. Kresse H., Hausser H., Schonherr E., Bittner K. Biosynthesis and interactions of small chondroitin/dermatan sulphate proteoglycans. Eur. J. Clin. Chem. Clin. Biochem. 1994, 32:259-264.
5. Karvonen R.L., Fernandez-Madrid F., Lande M.A., Hazlett L., Barrett R., An T., Huebner C.J. Proteoglycans from osteoarthritic human articular cartilage influence type II collagen in vitro fibrillogenesis. Connect. Tissue Res. 1992, 27:235-250.
6. Wiberg C., Heinegard D., Wenglen C., Timpl R., Morgelin M. Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J. Biol. Chem. 2002, 277:49120-49126.
7. Babelova A., Moreth K., Tsalastra-Greul W., Zeng-Brouwers J., Eickelberg O., Young M.F., Bruckner P., Pfeilschifter J., Schaefer R.M., Grone H.J., Schaefer L. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J. Biol. Chem. 2009, 284:24035-24048.
8. Schaefer L., Babelova A., Kiss E., Hausser H.J., Baliova M., Krzyzankova M., Marsche G., Young M.F., Mihalik D., Gotte M., Malle E., Schaefer R.M., Grone H.J. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 2005, 115:2223-2233.
9. Bi Y., Stuelten C.H., Kilts T., Wadhwa S., Iozzo R.V., Robey P.G., Chen X.D., Young M.F. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J. Biol. Chem. 2005, 280:30481-30489.
10. Chen X.D., Fisher L.W., Robey P.G., Young M.F. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J. 2004, 18:948-958.
11. Mochida Y., Parisuthiman D., Yamauchi M. Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation. Adv. Exp. Med. Biol. 2006, 585:101-113.
12. Parisuthiman D., Mochida Y., Duarte W.R., Yamauchi M. Biglycan modulates osteoblast differentiation and matrix mineralization. J. Bone Miner. Res. 2005, 20:1878-1886.
13. Moreno M., Munoz R., Aroca F., Labarca M., Brandan E., Larrain J. Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. EMBO J. 2005, 24:1397-1405.
14. Matsuno Y.K., Yamada K., Tanabe A., Kinoshita M., Maruyama S.Z., Osaka Y.S., Masuko T., Kakehi K. Development of an apparatus for rapid release of oligosaccharides at the glycosaminoglycan-protein linkage region in chondroitin sulfate-type proteoglycans. Anal. Biochem. 2007, 362:245-257.
15. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 1994, 127:1755-1766.
16. Kaku M., Mochida Y., Atsawasuwan P., Parisuthiman D., Yamauchi M. Post-translational modifications of collagen upon BMP-induced osteoblast differentiation. Biochem. Biophys. Res. Commun. 2007, 359:463-468.
17. Zellin G., Linde A. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J. Biomed. Mater. Res. 1997, 35:181-190.
18. Arosarena O.A., Falk A., Malmgren L., Bookman L., Allen M.J., Schoonmaker J., Tatum S., Kellman R. Defect repair in the rat mandible with bone morphogenic proteins and marrow cells. Arch. Facial Plast. Surg. 2003, 5:103-108.
19. Arosarena O.A., Collins W.L. Bone regeneration in the rat mandible with bone morphogenetic protein-2: a comparison of two carriers. Otolaryngol. Head Neck Surg. 2005, 132:592-597.
20. Arosarena O., Collins W. Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses. Orthod Craniofac. Res. 2005, 8:267-276.
21. Fisher L.W., Hawkins G.R., Tuross N., Termine J.D. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J. Biol. Chem. 1987, 262:9702-9708.
22. Bianco P., Fisher L.W., Young M.F., Termine J.D., Robey P.G. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 1990, 38:1549-1563.
23. Balint E., Lapointe D., Drissi H., van der Meijden C., Young D.W., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J. Cell. Biochem. 2003, 89:401-426.
24. Casar J.C., McKechnie B.A., Fallon J.R., Young M.F., Brandan E. Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev. Biol. 2004, 268:358-371.
25. Wang X., Harimoto K., Xie S., Cheng H., Liu J., Wang Z. Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways. Biol. Pharm. Bull. 2010, 33:1891-1897.
26. Chen C.C., Boskey A.L. Mechanisms of proteoglycan inhibition of hydroxyapatite growth. Calcif. Tissue Int. 1985, 37:395-400.
27. Boskey A.L., Spevak L., Doty S.B., Rosenberg L. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif. Tissue Int. 1997, 61:298-305.
28. Casu B., Petitou M., Provasoli M., Sinay P. Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem. Sci. 1988, 13:221-225.
29. Schonherr E., Witsch-Prehm P., Harrach B., Robenek H., Rauterberg J., Kresse H. Interaction of biglycan with type I collagen. J. Biol. Chem. 1995, 270:2776-2783.
30. Raspanti M., Viola M., Forlino A., Tenni R., Gruppi C., Tira M.E. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. J. Struct. Biol. 2008, 164:134-139.
31. Sugars R.V., Milan A.M., Brown J.O., Waddington R.J., Hall R.C., Embery G. Molecular interaction of recombinant decorin and biglycan with type I collagen influences crystal growth. Connect. Tissue Res. 2003, 44(Suppl. 1):189-195.
32. Pogany G., Hernandez D.J., Vogel K.G. The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. Arch. Biochem. Biophys. 1994, 313:102-111.